CYCC Projected Dividend Yield
Com Par $.001 (New) 2023/Cyclacel Pharmaceuticals Inc ( NASDAQ : CYCC )Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The epigenetic/anti-mitotic program is evaluating plogosertib, in solid tumors and hematological malignancies. 10 YEAR PERFORMANCE RESULTS |
CYCC Dividend History Detail CYCC Dividend News CYCC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2025 |
Apr 23, 2025 |
Apr 29, 2025 |
Apr 29, 2025 |
May 01, 2025 |
0.1500 |
2025 Total: |
0.1500 |